Bamco Inc Recursion Pharmaceuticals, Inc. Transaction History

Bamco Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $2.52 Million - $7.37 Million	-408,563 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.14 - $21.86 $4.64 Million - $6.28 Million	-287,237 Reduced 41.28%	408,563 $7 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $5.15 Million - $11.2 Million	270,800 Added 63.72%	695,800 $16 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $7.65 Million - $15.9 Million	425,000 New	425,000 $15.5 Million

260

193M

787K

1.52M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.34B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.